MedPath

AVANDAMET

AVANDAMET

Discontinued
DIN Number

02248441

Drug Class

Human

Market Date

Jan 19, 2004

Company
HC

GlaxoSmithKline Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02248441
AIG Number0248901005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BD03 METFORMIN AND ROSIGLITAZONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.04
Health Canada Classification

ACTIVE INGREDIENTS (2)

METFORMIN HYDROCHLORIDEActive
Strength: 1000 MG
Monograph: METFORMIN HYDROCHLORIDE
ROSIGLITAZONE (ROSIGLITAZONE MALEATE)Active
Strength: 4.00 MG
Monograph: ROSIGLITAZONE (ROSIGLITAZONE MALEATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.